Search

Your search keyword '"Zuo, Zhiheng"' showing total 13 results
Start Over Author "Zuo, Zhiheng" Search Limiters Full Text
13 results on '"Zuo, Zhiheng"'

1. LOCx2, a Low-latency, Low-overhead, 2 x 5.12-Gbps Transmitter ASIC for the ATLAS Liquid Argon Calorimeter Trigger Upgrade

Author

Xiao, Le, Li, Xiaoting, Gong, Datao, Chen, Jinghong, Guo, Di, He, Huiqin, Hou, Suen, Huang, Guangming, Liu, Chonghan, Liu, Tiankuan, Sun, Xiangming, Teng, Ping-Kun, Vosooghi, Bozorgmehr, Xiang, Annie C., Ye, Jingbo, You, Yang, and Zuo, Zhiheng

Subjects
Physics - Instrumentation and Detectors
Abstract

In this paper, we present the design and test results of LOCx2, a transmitter ASIC for the ATLAS Liquid Argon Calorimeter trigger upgrade. LOCx2 consists of two channels and each channel encodes ADC data with an overhead of 14.3% and transmits serial data at 5.12 Gbps with a latency of less than 27.2 ns. LOCx2 is fabricated with a commercial 0.25-um Silicon-on-Sapphire CMOS technology and is packaged in a 100-pin QFN package. The power consumption of LOCx2 is about 843 mW.

Published
2020
Full Text
View/download PDF

4. Recent Advances in the Pathogenesis of Glucolipid Metabolism Disorder in Obstructive Sleep Apnea-hypopnea Syndrome

Author

WANG Yun, HE Yan, LIU Shijie, GAN Lulu, GAO Huifang, LIANG Min, ZUO Zhiheng, YANG Li

Subjects
sleep apnea, obstructive, osahs, glucose metabolism, lipid metabolism, insulin resistance, cardiovascular diseases, review, Medicine
Abstract

Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a disease marked by apnea, hypopnea, decreased oxygen saturation, and disordered sleep structure, which is a major risk for cardiovascular disease. Recent studies have found that OSAHS patients have an increased risk of hypertension, coronary atherosclerotic heart disease, insulin resistance, type 2 diabetes, metabolic syndrome, non-alcoholic fatty liver disease, etc. And these patients have a high prevalence of obvious glucolipid metabolism disorder (GMD) , which plays an important role in cardiovascular morbidity and mortality in OSAHS. We reviewed the latest advances in the association of GMD and OSAHS, and the potential pathogenesis of OSAHS-induced GMD and insulin resistance, aiming at providing new ideas for clinical treatment of GMD in OSAHS.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results